Xylyx Bio
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
760 Parkside Ave Ste 321, Brooklyn, New ...Phone Number
(212) 689-9005Website
www.xylyxbio.comRevenue
$6.2 MillionIndustry
About Xylyx Bio
Xylyx Bio Org Chart
Is Xylyx Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if Xylyx Bio is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Xylyx Bio had a recent Job posting/layoffs
Xylyx Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Xylyx Bio has new funding data
Congratulate Masked Content for being promoted to Masked Content at Xylyx Bio
Earning: See what the market has to say on Xylyx Bio recently announced quarterly report
Check if Xylyx Bio has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Xylyx Bio launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Xylyx Bio
Compare insights from companies similar to Xylyx Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Xylyx Bio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Xylyx Bio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Xylyx Bio.
Xylyx Bio Tech Stack
A closer look at the technologies used by Xylyx Bio
Most Recent Scoops
Xylyx Bio News & Media
Xylyx Bio awarded $2.45M NIH SBIR grant from NIDDK to facilitate development of effective drugs for fibrotic liver disease
Award supports the development of a cell-based assay platform to help scientists discover and test drug candidates for liver fibrosis BROOKLYN, N.Y., Sept. 16, 2024 /PRNewswire/ -- Xylyx Bio, Inc., a regenerative medicine company developing pioneering solutions for tissue and organ...Xylyx Bio announces exclusive license agreement with Vanderbilt University for donor organ rehabilitation asset
By rehabilitating donor organs deemed unfit for transplant, the xenogeneic cross-circulation platform holds potential to eliminate transplant waitlist mortality. NEW YORK, May 8, 2024 /PRNewswire/ -- Xylyx Bio, a regenerative medicine company developing innovative solutions for tissue and...Xylyx Bio and Alec Batis partner to launch Sweet Chemistry, a groundbreaking line of evidence-based regenerative skincare products
Xylyx Bio's pioneering biotechnology combined with Batis' world-class formulation expertise creates a game-changing partnership at the nexus of regenerative medicine and cosmetic science. NEW YORK, Aug. 1, 2023 /PRNewswire/ -- Xylyx Bio, a regenerative medicine company, and Alec Batis, a...Clinical study shows Xylyx Bio's Matrikynes® significantly improves the structure, function, and appearance of skin
Independent clinical study results validate Matrikynes® efficacy in reversing common signs of skin damage and aging, including reduction of lines and wrinkles. NEW YORK, April 5, 2023 /PRNewswire/ -- Xylyx Bio, a regenerative medicine company developing breakthrough technologies for organ...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Xylyx Bio
Xylyx Bio is an innovative biotechnology company focused on bioengineered human organs for clinical transplantation. Their mission is to transform transplant medicine by significantly increasing the availability of human organs for patients suffering from chronic diseases who are in need of transplants. The company offers first-in-class human organ... Read More